
Bioorganic and Medicinal Chemistry Letters p. 2907 - 2912 (1996)
Update date:2022-08-02
Topics:
Pinto, Donald J.P.
Copeland, Robert A.
Covington, Maryanne B.
Pitts, William J.
Batt, Douglas G.
Orwat, Michael J.
Lam, Gilbert N.
Joshi, Amita
Chan, Yuk-Charn
Wang, Shuaige
Trzaskos, James M.
Magolda, Ronald L.
Kornhauser, David M.
DuP697, 2-bromo-4-(4'-sulfonylmethyl)phenyl-5-(4'-fluoro)phenylthiophene, is a selective type 2 cyclooxygenase (COX-2) inhibitor. Its relatively weak COX-2 selectivity coupled with a poor human pharmacokinetic profile led us to seek improvements on the in vitro selectivity while at the same time, addressing some of its pharmacokinetic liabilities. In this paper we discuss some strategies at solving the PK issue within a class of COX-2 inhibitors. The result of these efforts led to the discovery of a new class of COX-2 inhibitors the terphenyls, which prove to be superior alternatives to the diarylthiophenes.
View MoreContact:+86-021-6989-5597
Address:No.80 Yichuan Rd., Putuo District,Shanghai,P.R.China
Xinji City Taida Sinopec Co., Ltd.
Contact:0086-311-85341278
Address:No.6, Nanhua Road,Xinji City Road,Hebei Province,China
Contact:+33-5-34012600
Address:28 ZA des Pignès
website:https://www.yurisolar.com/en
Contact:86--18092602675
Address:No. 560, East Hangtian Road, Xi'an, China
Chengda Pharmaceuticals Co., Ltd.
Contact:+86-573-84601188
Address:hengshan Road 5# in Jiashan, zhejiang
Doi:10.1039/c3dt52753k
(2014)Doi:10.1002/ejoc.201301301
(2014)Doi:10.1021/ol5005565
(2014)Doi:10.1039/c4cc07921c
(2014)Doi:10.1055/s-2006-950371
(2006)Doi:10.1134/S1070428014020043
(2014)